Use of Second-line Immunotherapy in Control Arms of Randomized Clinical Trials in Kidney Cancer A Systematic Review
JAMA network open（2021）
Key words
Combination Therapies,Cancer Immunoediting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined